Search

everythinglearnresearchcommunity

for

Search:↓

A woman's high testosterone levels were caused by a rare ovarian tumor, not the initially diagnosed condition.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

New treatments for male hypogonadism are effective and should be personalized.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Tamoxifen effectively treats gynecomastia without causing impotence.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.